MEDISTEND

Details for Australian Trade Mark No. 1289492 (hide)

Owner Eli Lilly and Company incorporated in the State

Convention US 16 September 2008 77/570984

Service Spruson & Ferguson

Various Convention priority claimed: 16 September 2008, United States of America, No. 77/570984 in respect of TRANSDERMAL DRUG DELIVERY TECHNOLOGY AND PRODUCTS FOR USE ON COMPANION AND FOOD ANIMALS, NAMELY, SKIN PENETRATION MEDICINE.

Filing Date 12 March 2009

Classes

Class 5 Transdermal drug delivery technology and products for use on companion and food animals, including skin preparation medicine for paint and inflammation

Event Publications

9 April 2009 Application filed

23 April 2009 Application Accepted

20 August 2009 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1289493-TRANSENTRA

1289491